Romiplostim in Chemotherapy-Induced Thrombocytopenia

Clinical trial NCT06201663 · UNKNOWN

Trial details

NCT number: NCT06201663
Sponsor: Ain Shams University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Chemotherapy-induced Thrombocytopenia Solid Malignancy

Start date: 2023-12-17
Primary completion: 2025-05-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.